tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Teva Pharmaceutical Industries Ltd

TEVA
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
44.500USD
+0.850+1.95%
์ข…๊ฐ€ย 11-13 16:00๏ผˆET๏ผ‰
51.86B์‹œ๊ฐ€์ด์•ก
36.18P/E TTM
์žฅ์™ธ ๊ฑฐ๋ž˜ย 19:00ย (ET)44.500USD-0.015-0.03%

Teva Pharmaceutical Industries Ltd

44.500
+0.850+1.95%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

TEVA ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Teva Pharmaceutical Industries Ltd์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
51.86B
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
36.18
์ฃผ๋‹น์ˆœ์ด์ต
1.23
์ˆ˜์ต
17.32B
์ˆœ์ด์ต
-1.64B
ROE
21.60%
ROA
3.99%
Teva Pharmaceutical Industries Ltd ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Nov 3, 2026
EPS / ์˜ˆ์ƒ
0.20/0.72
์ˆ˜์ต / ์˜ˆ์ƒ
4.37B/4.22B

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-47.07%0.20
-301.10%-0.49
69.74%0.32
318.50%0.42
197.88%0.38
132.93%0.25
251.92%0.19
-149.91%-0.19
-726.65%-0.39
4.09%-0.75
37.27%-0.12
132.47%0.38
--0.06
---0.78
---0.20
---1.18
---1.02
----
----
----
์ˆ˜์ต
-2.24%4.37B
-1.38%4.15B
2.06%3.97B
11.73%4.72B
3.42%4.48B
0.29%4.18B
1.89%3.89B
-5.58%4.23B
12.52%4.33B
7.37%4.16B
4.32%3.82B
13.62%4.48B
8.12%3.85B
2.89%3.88B
0.52%3.66B
-3.81%3.94B
-8.01%3.56B
-3.97%3.77B
-7.89%3.64B
-8.40%4.10B
์ˆœ์ด์ต
-46.19%233.00M
-304.26%-576.00M
72.43%369.00M
321.20%480.00M
199.08%433.00M
133.33%282.00M
253.96%214.00M
-150.58%-217.00M
-733.33%-437.00M
2.98%-846.00M
36.82%-139.00M
132.65%429.00M
23.21%69.00M
-275.86%-872.00M
76.96%-220.00M
-726.42%-1.31B
-80.82%56.00M
-212.08%-232.00M
-1340.26%-955.00M
-206.00%-159.00M
์ˆœ์ด์ต๋ฅ 
-44.85%5.35%
-304.45%-13.86%
64.35%9.29%
256.55%10.18%
207.61%9.69%
132.29%6.78%
151.53%5.65%
-167.26%-6.50%
-550.14%-9.00%
10.16%-20.99%
-58.76%-10.97%
128.31%9.67%
--2.00%
---23.36%
---6.91%
---34.15%
---10.51%
----
----
----
์ด ์ด์ต๋ฅ 
4.99%55.16%
1.14%52.29%
0.29%49.36%
10.22%56.74%
3.58%52.70%
3.20%51.70%
5.36%49.22%
-8.14%51.48%
2.66%50.88%
1.13%50.10%
8.31%46.71%
2.37%56.04%
--49.56%
--49.54%
--43.13%
--54.74%
--48.02%
----
----
----
๋ถ€์ฑ„๋น„์œจ
-0.89%41.75%
-3.02%41.63%
-4.20%41.53%
-8.79%41.25%
-7.32%42.13%
-4.81%42.93%
-5.62%43.35%
-0.87%45.22%
-4.23%45.45%
-6.02%45.09%
-3.54%45.93%
-5.36%45.62%
--47.46%
--47.98%
--47.61%
--48.20%
--48.06%
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
-2.24%4.37B
-1.38%4.15B
2.06%3.97B
11.73%4.72B
3.42%4.48B
0.29%4.18B
1.89%3.89B
-5.58%4.23B
12.52%4.33B
7.37%4.16B
4.32%3.82B
13.62%4.48B
8.12%3.85B
2.89%3.88B
0.52%3.66B
-3.81%3.94B
-8.01%3.56B
-3.97%3.77B
-7.89%3.64B
-8.40%4.10B
์˜์—… ์ด์ต
6.73%1.19B
-78.18%213.00M
-1.78%772.00M
37.38%1.31B
6.43%1.13B
8.06%952.00M
20.18%786.00M
-31.15%955.00M
29.18%1.06B
9.58%881.00M
29.50%654.00M
28.07%1.39B
16.01%819.00M
12.13%804.00M
-34.33%505.00M
11.76%1.08B
-10.63%706.00M
-15.05%717.00M
0.39%769.00M
20.97%969.00M
์ˆœ์ด์ต
-46.19%233.00M
-304.26%-576.00M
72.43%369.00M
321.20%480.00M
199.08%433.00M
133.33%282.00M
253.96%214.00M
-150.58%-217.00M
-733.33%-437.00M
2.98%-846.00M
36.82%-139.00M
132.65%429.00M
23.21%69.00M
-275.86%-872.00M
76.96%-220.00M
-726.42%-1.31B
-80.82%56.00M
-212.08%-232.00M
-1340.26%-955.00M
-206.00%-159.00M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
14.65%14.60B
9.03%13.76B
18.93%13.71B
11.11%13.95B
3.43%12.74B
8.49%12.62B
-6.25%11.53B
0.54%12.55B
7.78%12.31B
-3.77%11.63B
6.92%12.30B
3.60%12.48B
-0.24%11.43B
-0.62%12.09B
-7.63%11.50B
-4.15%12.05B
-5.77%11.45B
-5.13%12.16B
0.40%12.45B
-3.32%12.57B
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
34.24%15.43B
31.91%15.65B
21.29%13.53B
5.16%13.46B
-16.71%11.49B
-9.02%11.86B
-19.11%11.16B
4.48%12.80B
21.09%13.80B
10.08%13.04B
32.48%13.79B
6.78%12.25B
-1.21%11.39B
7.70%11.84B
-10.35%10.41B
4.01%11.47B
-2.46%11.53B
-13.36%11.00B
-3.94%11.61B
-16.23%11.03B
์ด ์ž์‚ฐ
0.47%40.04B
-0.68%39.86B
4.23%40.04B
3.62%40.75B
-4.55%39.86B
-2.92%40.13B
-10.19%38.41B
-9.55%39.33B
-0.78%41.76B
-4.08%41.34B
-1.57%42.77B
-1.21%43.48B
-4.89%42.09B
-6.18%43.09B
-7.66%43.46B
-7.67%44.01B
-7.52%44.25B
-6.63%45.93B
-3.97%47.06B
-5.87%47.67B
๋ถ€์ฑ„ ์ด๊ณ„
-1.67%32.06B
-3.59%32.10B
-1.05%31.81B
-3.28%32.83B
-7.84%32.60B
-4.25%33.30B
-8.75%32.15B
-3.98%33.95B
2.31%35.38B
-1.73%34.77B
1.11%35.23B
-0.17%35.35B
-0.45%34.58B
-1.99%35.39B
-5.31%34.84B
-2.77%35.41B
-4.58%34.73B
-4.70%36.10B
-3.23%36.80B
-7.98%36.42B
์ž๋ณธ ์ด๊ณ„
10.06%7.98B
13.51%7.76B
31.31%8.23B
47.10%7.91B
13.65%7.25B
4.13%6.83B
-16.89%6.27B
-33.79%5.38B
-15.03%6.38B
-14.85%6.56B
-12.41%7.54B
-5.49%8.13B
-21.08%7.51B
-21.57%7.71B
-16.06%8.61B
-23.53%8.60B
-16.87%9.52B
-13.11%9.83B
-6.51%10.26B
1.65%11.24B
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-34.69%241.00M
81.06%411.00M
61.90%-40.00M
101.39%1.16B
-46.75%369.00M
118.27%227.00M
16.00%-105.00M
-51.44%575.00M
13760.00%693.00M
-67.90%104.00M
13.79%-125.00M
21.69%1.18B
-99.08%5.00M
165.57%324.00M
-195.92%-145.00M
113.38%973.00M
2.84%544.00M
-44.04%122.00M
87.90%-49.00M
37.76%456.00M
์ˆœํˆฌ์ž
55.56%210.00M
-308.05%-491.00M
13.93%229.00M
-18.32%165.00M
-49.63%135.00M
32.58%236.00M
39.58%201.00M
-32.89%202.00M
45.65%268.00M
-41.06%178.00M
-20.44%144.00M
79.17%301.00M
25.17%184.00M
67.78%302.00M
12.42%181.00M
-31.71%168.00M
-48.96%147.00M
-62.58%180.00M
-68.31%161.00M
74.47%246.00M
์ˆœ์žฌ๋ฌดํ™œ๋™
101.32%6.00M
-116.67%-1.00M
100.75%13.00M
105.93%40.00M
---453.00M
100.62%6.00M
-1054.97%-1.74B
-17.01%-674.00M
100.00%0.00
-1656.36%-966.00M
78.61%-151.00M
18.99%-576.00M
-30.91%-576.00M
83.73%-55.00M
-35400.00%-706.00M
-41.92%-711.00M
62.62%-440.00M
-33700.00%-338.00M
100.41%2.00M
-300.80%-501.00M

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Teva Pharmaceutical Industries Ltd์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 17.32B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 16.51B์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 13.95B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 11.11์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Teva Pharmaceutical Industries Ltd์˜ ์ด์ž์‚ฐ์€ 40.75B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 3.62์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Teva Pharmaceutical Industries Ltd์˜ ์ด๋ถ€์ฑ„๋Š” 32.83B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -3.28์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Teva Pharmaceutical Industries Ltd์˜ ์ด์ž๋ณธ์€ 7.91B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 47.10์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Teva Pharmaceutical Industries Ltd์˜ ์ˆœ์˜์—…์†Œ๋“์€ 4.20B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 17.87์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Teva Pharmaceutical Industries Ltd์˜ ์ˆœํˆฌ์ž๋Š” 737.00M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -6.94์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Teva Pharmaceutical Industries Ltd์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ -2.15B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -20.10์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ 1.23์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 184.98์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ 1.41B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 186.03์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ 8.19์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 168.99์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 53.00์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 6.02์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋ถ€์ฑ„/์ž์‚ฐ ๋น„์œจ์€ 41.25์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -8.79์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ 21.23์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 183.41์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ 3.54์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 174.85์ž…๋‹ˆ๋‹ค.

Teva Pharmaceutical Industries Ltd์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Teva Pharmaceutical Industries Ltd์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ 4.20B์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 17.87์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ